Benazepril 2 mg/mL oral suspension
- Concentration
- 2 mg/mL
- Batch
- 150 mL
- From
- 15 × 20 mg tablets
- Vehicles named
- Ora-Plus, Ora-Sweet
- Container
- amber polyethylene terephthalate (PET) bottle
The label's instructions
2.3 Preparation of Suspension (for 150 mL of a 2 mg/mL Suspension) Add 75 mL of Ora-Plus®* oral suspending vehicle to an amber polyethylene terephthalate (PET) bottle containing fifteen Lotensin 20 mg tablets, and shake for at least two minutes. Allow the suspension to stand for a minimum of 1 hour. After the standing time, shake the suspension for a minimum of one additional minute. Add 75 mL of Ora-Sweet®* oral syrup vehicle to the bottle and shake the suspension to disperse the ingredients. The suspension should be refrigerated at 2º to 8°C (36º to 46°F) and can be stored for up to 30 days in the PET bottle with a child-resistant screw- cap closure. Shake the suspension before each use. *Ora-Plus® and Ora-Sweet® are registered trademarks of Paddock Laboratories, Inc. Ora Plus® contains carrageenan, citric acid, methylparaben, microcrystalline cellulose, carboxymethylcellulose sodium, potassium sorbate, simethicone, sodium phosphate monobasic, xanthan gum, and water. Ora-Sweet® contains citric acid, berry citrus flavorant, glycerin, methylparaben, potassium sorbate, sodium phosphate monobasic, sorbitol, sucrose, and water.
Quoted verbatim from the Dosage and Administration section of the FDA label for Lotensin, version 10, effective 2025-09-30. Open the label on DailyMed. 56 current labels for this drug carry these instructions.
Storage and beyond-use date
| Storage | BUD | Basis |
|---|---|---|
| Refrigerated | 30 days | Storage and duration as the FDA label states them. |
- “The suspension should be refrigerated at 2º to 8°C (36º to 46°F) and can be stored for up to 30 days in the PET bottle with a child-resistant screw- cap closure.”
Only the storage conditions the source covers are listed. Use the BUD assistant for other cases. The BUD may not be later than any component's expiration date. Verify against the current official USP chapter.
Ingredient checks
No FDA compounding list or NIOSH flags for the active ingredient.
Source
FDA label (Lotensin), Dosage and Administration.
For licensed clinicians. Use with clinical judgment.